Cancer Diagnostics Market set to exceed USD 156 billion by 2024

Increasing government initiatives to spread awareness pertaining to benefits of early diagnosis will boost cancer diagnostics market growth over the forecast timeframe.

Delaware, Selbyville - June 13, 2019 /MarketersMedia/ —

Cancer Diagnostics Market is set to exceed USD 156 billion by 2024; according to a new research report.
Increasing prevalence of cancer across the globe will be major driving factor for cancer diagnostics market. World Health Organization reported that cancer accounted for 8.8 million deaths in 2015 and was second leading cause of mortality. Unhealthy eating habits and changing lifestyle are further expected to boost prevalence in near future rendering significant positive impact on demand for better cancer diagnostic methods.

Increasing government initiatives to spread awareness pertaining to benefits of early diagnosis will boost cancer diagnostics market growth over the forecast timeframe. Awareness and accessibility of cancer diagnostic products is lower in developing and underdeveloped regions. Private as well as government organizations are conducting awareness campaigns to educate people regarding the importance of early diagnosis. Such activities will influence industrial growth. For instance, Roche in partnership with China Cancer Rehabilitation Society (CCRS) conducted ‘Run for Her' campaign to raise awareness about mammography.

Request a sample of this premium report titled at https://www.marketstudyreport.com/request-a-sample/859978/?utm_source=MM-VHS

Recent technological advancements enabling quick and accurate diagnosis will propel cancer diagnostics market growth. Patients are receiving treatment specifically tailored with accordance to their genetic makeup with the help of diagnosis based of next generation sequencing and liquid biopsy. Advent of such technologies in near future will support industry growth.

However, prohibitive cost of diagnosis is hampering adoption rates in countries with low income levels. Risk of radiations exposure will further impede market growth over the forecast period.

Imaging application segment held largest revenue share in 2016 and the trend is expected to continue over the forecast timeframe owing to wide range of applicability of imaging devices to detect majority of cancer types. Advent of technologically advanced devices such as computed tomography and positron emission tomography devices will positively impact market growth. These devices provide high quality imaging at lower radiation dose. The side effects associated with usage of some conventional imaging devices due to radiation exposure will hinder segment growth to some extent.

The liver-lung cancer application segment accounted for majority of market share in 2016. The segment growth is largely supported by increasing prevalence due to changing dietary habits such as increasing alcohol consumption and smoking.

U.S. dominated cancer diagnostics market in 2016, due to high research and development activities focused at developing better diagnostic methods. Presence of leading medical technology and biotechnology firms coupled with high adoption rates of technologically superior diagnostic methods will drive the U.S. cancer diagnostics market growth over the forecast timeframe.

China cancer diagnostic market should witness robust growth due to presence of large patient pool and increasing disposable income. Growing awareness pertaining to benefits of early diagnosis will propel market growth. However, being a price sensitive market, inflated cost of some advanced diagnostic tests may limit regional growth to some extent.

Request a discount on standard prices of this premium report titled at https://www.marketstudyreport.com/check-for-discount/859978/?utm_source=MM-VHS

Some of the key industry players operating in global cancer diagnostics market are Sienna Cancer Diagnostics, F. Hoffmann-La Roche, Becton, Dickinson and Company, C.R. Bard, Qiagen, Abbott Laboratories, Hoffmann-La Roche, Thermo Fisher Scientific, Siemens AG, Bio Rad Laboratories, GE Healthcare, Illumina, Koninklijke Philips, Toshiba Medical Systems Corporation, Agilent Technologies, and Hologic. Industry players are trying to garner higher market share through various organic as well as inorganic growth strategies. The companies in the industry are further trying to develop cost-effective and accurate diagnostics methods to get a competitive edge.

Report Content

Chapter 1. Methodology

1.1. Methodology

1.1.1. Initial data exploration

1.1.2. Statistical model and forecast

1.1.3. Industry insights and validation

1.1.4. Market definition and forecast parameters

1.2. Data sources

1.2.1. Secondary

1.2.2. Primary

Chapter 2. Executive Summary

2.1. Cancer diagnostics industry 360 degree synopsis, 2013 - 2024

2.1.1. Business trends

2.1.2. Application trends

2.1.3. Cancer type trends

2.1.4. End-use trends

2.1.5. Regional trends

Chapter 3. Cancer Diagnostics Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2013 - 2024

3.3. Industry impact forces

3.3.1. Growth drivers

3.3.2. Industry pitfalls & challenges

3.4. Growth potential analysis

3.4.1. By application

3.4.2. By cancer type

3.4.3. By end-use

3.5. Regulatory landscape

3.5.1. U.S

3.5.2. Europe

3.6. Porter's analysis

3.7. Competitive landscape, 2016

3.7.1. Business overview

3.7.2. Revenue analysis

3.7.3. Product landscape

3.7.4. Strategy dashboard

3.8. PESTEL analysis

Chapter 4. Cancer Diagnostics Market, By Application

4.1. Global cancer diagnostics market share, by application, 2016 & 2024

4.2. Tumor biomarkers tests

4.2.1. Market estimates and forecast, by region, 2013 - 2024

4.3. Imaging

4.3.1. Market estimates and forecast, by region, 2013 - 2024

4.3.1.1. Ultrasound and Radiology

4.3.1.1.1. Market estimates and forecast, by region, 2013 - 2024

4.3.1.2. Mammography

4.3.1.2.1. Market estimates and forecast, by region, 2013 - 2024

4.3.1.3. MRI Scan

4.3.1.3.1. Market estimates and forecast, by region, 2013 - 2024

4.3.1.4. PET Scan

4.3.1.4.1. Market estimates and forecast, by region, 2013 - 2024

4.3.1.5. CT Scan

4.3.1.5.1. Market estimates and forecast, by region, 2013 - 2024

4.3.1.6. SPECT & Others

4.3.1.6.1. Market estimates and forecast, by region, 2013 - 2024

4.4. Biopsy

4.4.1. Market estimates and forecast, by region, 2013 - 2024

4.5. Liquid Biopsy

4.5.1. Market estimates and forecast, by region, 2013 - 2024

4.6. Immunohistochemistry

4.6.1. Market estimates and forecast, by region, 2013 - 2024

4.7. In Situ Hybridization

4.7.1. Market estimates and forecast, by region, 2013 - 2024

Chapter 5. Cancer Diagnostics Market, By Cancer type

5.1. Global cancer diagnostics market share, by cancer type, 2016 & 2024

5.2. Bladder Cancer

5.2.1. Market estimates and forecast, by region, 2013 - 2024

5.3. Breast Cancer

5.3.1. Market estimates and forecast, by region, 2013 - 2024

5.4. Colon and Rectal Cancer

5.4.1. Market estimates and forecast, by region, 2013 - 2024

5.5. Endometrial Cancer

5.5.1. Market estimates and forecast, by region, 2013 - 2024

5.6. Kidney Cancer

5.6.1. Market estimates and forecast, by region, 2013 - 2024

5.7. Leukemia

5.7.1. Market estimates and forecast, by region, 2013 - 2024

5.8. Liver-Lung Cancer

5.8.1. Market estimates and forecast, by region, 2013 - 2024

5.9. Melanoma

5.9.1. Market estimates and forecast, by region, 2013 - 2024

5.10. Non-Hodgkin Lymphoma

5.10.1. Market estimates and forecast, by region, 2013 - 2024

5.11. Pancreatic Cancer

5.11.1. Market estimates and forecast, by region, 2013 - 2024

5.12. Prostate Cancer

5.12.1. Market estimates and forecast, by region, 2013 - 2024

5.13. Thyroid Cancer

5.13.1. Market estimates and forecast, by region, 2013 - 2024

5.14. Others

5.14.1. Market estimates and forecast, by region, 2013 - 2024

Complete report titled at https://www.marketstudyreport.com/reports/cancer-diagnostics-market

About Us:

Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Info:
Name: Arun Hegde
Email: Send Email
Organization: Market Study Report
Address: 4 North Main Street, Selbyville, Delaware 19975 USA
Phone: 1-302-273-0910
Website: https://www.marketstudyreport.com/

Source URL: https://marketersmedia.com/cancer-diagnostics-market-set-to-exceed-usd-156-billion-by-2024/523987

Source: MarketersMedia

Release ID: 523987

More News From travelstylo.com

New Mexico mural focuses on missing Native American women

Jun 19, 2019

LAS CRUCES, N.M. — A new mural in southern New Mexico seeks to honor missing and slain Native Americans amid a nationwide push to bring more attention to the issue. The Las Cruces Sun-News reports artist Sebastian "Vela" Velazquez recently erected the mural in Las Cruces in conjunction with the city's eighth annual "Illegal" graffiti art show. The work is part of a large-scale mural wrapping around the entirety of the Cruces Creatives building. In the mural, a Native American woman stands in front with her fist raised. She's screaming and the words below say: "NO MORE STOLEN SISTERS!" "The...

Paris zoo gives orangutan Nenette a 50th birthday party

Jun 19, 2019

PARIS — Nenette, one of the world's oldest Borneo orangutans in captivity, has celebrated her 50th birthday at a zoo in Paris, where she has lived almost all her life. Birthday cake, wrapped boxes and visitors singing "Happy Birthday" were part of the party held Sunday for Nenette at Menagerie, a zoo in the Jardin des Plantes gardens. She was treated to exotic fruits and ate a strawberry cake. Some of her favorite activities — painting and do-it-yourself workshops — were also on the party's program. Nenette is one of the last orangutans living in a zoo to be born...

Versace to Emporio: Men's looks shine, literally, in Milan

Jun 19, 2019

MILAN — Milan Fashion Week for spring/summer menswear previews has started with a slightly different rhythm, with many mainstays not showing this season. It is a sign of the times that fashion houses are seeking new ways to reach their audiences, and slotting menswear into womenswear shows by now is old hat. Gucci and Bottega Veneta are among the houses choosing that path, and skipping the June round of shows. And this year, Pitti Uomo in Florence got a boost as the chosen venue for Ferragamo, which normally shows in Milan, and Givenchy, which makes Paris its home. Prada went...

Taylor Swift makes surprise performance at gay bar Stonewall

Jun 19, 2019

NEW YORK — Taylor Swift made a surprise performance at an iconic gay bar a day after releasing a song supporting the LGBTQ community. Swift celebrated Pride Month by appearing at New York City's Stonewall Inn on Friday night. She released her new tune Thursday called "You Need to Calm Down," where she calls out those who attack the LGBTQ community. The song is the second single from Swift's seventh album "Lover," which will be released Aug. 23. Swift sang her hit song "Shake It Off" at the New York City bar with "Modern Family" actor Jesse Tyler Ferguson, who...

Weld takes GOP bid to oust Trump to NH, voters confused.

Jun 19, 2019

DOVER, N.H. — Bill Weld has decided to focus his unlikely attempt to oust the sitting president on the maverick nature of the New Hampshire GOP primary. But as he's toured the state, the former Massachusetts governor has left Republicans and independents cold on President Donald Trump scratching their heads. He has joked about not kissing the back of a child's head because he doesn't want to be accused, like Joe Biden, of making people uncomfortable. He tells voters they wouldn't know how obese Americans truly are until they go to county fairs, where "those overalls are working overtime." And...

Broaden News

Travel Stylo is an independent online travel website started by a group of friends who love traveling together. With Travel Stylo, you can travel with style.

Contact us: sales[at]travelstylo.com